Sharma Vishal, Sharma Diksha, Saini Mamta, Jain Akash, Chaudhary Jasmine, Kaur Navgeet, Sahoo Samir, Singh Sachin Kumar, Goyal Kavita, Rekha A, Ali Haider, Gupta Saurabh, Hussain Md Sadique, Gupta Gaurav
M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana Ambala, India.
Department of Pharmacology, Swami Devi Dyal Institute of Pharmacy, Golpura, Barwala, India.
Curr Pharm Biotechnol. 2025 Jul 3. doi: 10.2174/0113892010384002250628163849.
Flavonoids, plant-derived polyphenolic compounds, have garnered significant attention for their broad-spectrum antimicrobial potential, encompassing antibacterial, antifungal, and antiviral activities. These bioactive molecules exert their effects through multiple mechanisms, including disruption of microbial cell membranes, inhibition of nucleic acid synthesis, suppression of biofilm formation, and interference with key bacterial enzymes. Notable flavonoids such as quercetin, apigenin, and kaempferol exhibit potent activity against bacterial pathogens like Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa, as well as fungal pathogens such as Aspergillus fumigatus and Candida albicans. Furthermore, flavonoids can potentiate the efficacy of conventional antibiotics by inhibiting bacterial efflux pumps, a critical mechanism contributing to antibiotic resistance. Recent advancements in structure-activity relationship (SAR) studies have underscored the influence of structural modifications- such as prenylation, hydroxylation, and methoxylation-on the antimicrobial potency of flavonoids. By highlighting these insights, this review provides a unique perspective on flavonoid-based antimicrobial strategies, particularly their synergistic potential with existing antibiotics. These findings position flavonoids as promising candidates for novel antimicrobial therapies, particularly in the face of increasing antibiotic-resistant pathogens. However, further research is needed to elucidate their precise mechanisms and optimize their therapeutic applications.
黄酮类化合物是植物来源的多酚类化合物,因其具有包括抗菌、抗真菌和抗病毒活性在内的广谱抗菌潜力而备受关注。这些生物活性分子通过多种机制发挥作用,包括破坏微生物细胞膜、抑制核酸合成、抑制生物膜形成以及干扰关键细菌酶。诸如槲皮素、芹菜素和山奈酚等著名的黄酮类化合物对大肠杆菌、金黄色葡萄球菌和铜绿假单胞菌等细菌病原体以及烟曲霉和白色念珠菌等真菌病原体表现出强大的活性。此外,黄酮类化合物可以通过抑制细菌外排泵来增强传统抗生素的疗效,而细菌外排泵是导致抗生素耐药性的关键机制。结构-活性关系(SAR)研究的最新进展强调了结构修饰(如异戊烯基化、羟基化和甲氧基化)对黄酮类化合物抗菌效力的影响。通过强调这些见解,本综述提供了关于基于黄酮类化合物的抗菌策略的独特观点,特别是它们与现有抗生素的协同潜力。这些发现使黄酮类化合物成为新型抗菌疗法的有希望的候选者,尤其是面对日益增加的抗生素耐药病原体时。然而,需要进一步研究以阐明其确切机制并优化其治疗应用。